

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuron cell-cell adhesion (GO:0007158) | 4.74557031 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 4.33238322 |
| 3 | locomotory exploration behavior (GO:0035641) | 4.17789738 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.13659726 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 4.13591846 |
| 6 | presynaptic membrane assembly (GO:0097105) | 4.10199937 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.02419113 |
| 8 | negative regulation of cell killing (GO:0031342) | 4.02419113 |
| 9 | vocalization behavior (GO:0071625) | 3.99609028 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.98978596 |
| 11 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.86841089 |
| 12 | neuron recognition (GO:0008038) | 3.82854226 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.82311767 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 3.81139159 |
| 15 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.78126633 |
| 16 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.72612899 |
| 17 | protein localization to synapse (GO:0035418) | 3.72371972 |
| 18 | presynaptic membrane organization (GO:0097090) | 3.69860549 |
| 19 | axonal fasciculation (GO:0007413) | 3.69536572 |
| 20 | postsynaptic membrane organization (GO:0001941) | 3.67943818 |
| 21 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.66407996 |
| 22 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.63468844 |
| 23 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.63152267 |
| 24 | cellular extravasation (GO:0045123) | 3.62928649 |
| 25 | positive regulation by symbiont of host defense response (GO:0052509) | 3.61461476 |
| 26 | modulation by symbiont of host defense response (GO:0052031) | 3.61461476 |
| 27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.61461476 |
| 28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.61461476 |
| 29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.61461476 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 3.61461476 |
| 31 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.59609898 |
| 32 | glutamate secretion (GO:0014047) | 3.57237126 |
| 33 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.55259116 |
| 34 | microglial cell activation (GO:0001774) | 3.54348563 |
| 35 | synaptic vesicle maturation (GO:0016188) | 3.52620064 |
| 36 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.48603736 |
| 37 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.45386527 |
| 38 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.39605124 |
| 39 | exploration behavior (GO:0035640) | 3.38084929 |
| 40 | glutamate receptor signaling pathway (GO:0007215) | 3.36442996 |
| 41 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.35629674 |
| 42 | cerebellar granule cell differentiation (GO:0021707) | 3.33629212 |
| 43 | neuron-neuron synaptic transmission (GO:0007270) | 3.26586738 |
| 44 | synaptic transmission, glutamatergic (GO:0035249) | 3.25884913 |
| 45 | macrophage activation (GO:0042116) | 3.25099198 |
| 46 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.24906820 |
| 47 | inositol phosphate catabolic process (GO:0071545) | 3.24903983 |
| 48 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.24128464 |
| 49 | regulation of beta-amyloid formation (GO:1902003) | 3.24107822 |
| 50 | inositol phosphate dephosphorylation (GO:0046855) | 3.22924480 |
| 51 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.22924480 |
| 52 | neuronal action potential propagation (GO:0019227) | 3.22510052 |
| 53 | regulation of synaptic vesicle transport (GO:1902803) | 3.20677237 |
| 54 | layer formation in cerebral cortex (GO:0021819) | 3.20594807 |
| 55 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.19821465 |
| 56 | dendrite morphogenesis (GO:0048813) | 3.18777990 |
| 57 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.18352373 |
| 58 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.16704496 |
| 59 | neurotransmitter secretion (GO:0007269) | 3.16226410 |
| 60 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.15883964 |
| 61 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.12719674 |
| 62 | adaptation of signaling pathway (GO:0023058) | 3.08241368 |
| 63 | detection of molecule of bacterial origin (GO:0032490) | 3.07977633 |
| 64 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.07425736 |
| 65 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.04499811 |
| 66 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.04356891 |
| 67 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.02659521 |
| 68 | response to host immune response (GO:0052572) | 3.02659521 |
| 69 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.01988445 |
| 70 | N-acetylneuraminate metabolic process (GO:0006054) | 3.00574498 |
| 71 | long-term synaptic potentiation (GO:0060291) | 2.98032241 |
| 72 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.97015084 |
| 73 | dendritic spine morphogenesis (GO:0060997) | 2.96022166 |
| 74 | response to peptidoglycan (GO:0032494) | 2.94202097 |
| 75 | negative regulation of interleukin-12 production (GO:0032695) | 2.91011287 |
| 76 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.90664217 |
| 77 | proline transport (GO:0015824) | 2.90007555 |
| 78 | transmission of nerve impulse (GO:0019226) | 2.89578336 |
| 79 | negative regulation of neurotransmitter transport (GO:0051589) | 2.88249942 |
| 80 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.86376024 |
| 81 | positive regulation of mast cell activation (GO:0033005) | 2.86089776 |
| 82 | neutrophil activation (GO:0042119) | 2.85506046 |
| 83 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.85108368 |
| 84 | auditory behavior (GO:0031223) | 2.84121027 |
| 85 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.83910024 |
| 86 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.83558518 |
| 87 | long-term memory (GO:0007616) | 2.83275660 |
| 88 | regulation of synapse structural plasticity (GO:0051823) | 2.82421362 |
| 89 | granulocyte activation (GO:0036230) | 2.79800604 |
| 90 | toxin transport (GO:1901998) | 2.78951446 |
| 91 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.78392152 |
| 92 | synaptic vesicle endocytosis (GO:0048488) | 2.78367381 |
| 93 | amino sugar catabolic process (GO:0046348) | 2.78234096 |
| 94 | regulation of postsynaptic membrane potential (GO:0060078) | 2.77949637 |
| 95 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.77841185 |
| 96 | gamma-aminobutyric acid transport (GO:0015812) | 2.77624019 |
| 97 | mating behavior (GO:0007617) | 2.77055472 |
| 98 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.76505682 |
| 99 | myeloid cell activation involved in immune response (GO:0002275) | 2.75896033 |
| 100 | axon ensheathment in central nervous system (GO:0032291) | 2.75793812 |
| 101 | central nervous system myelination (GO:0022010) | 2.75793812 |
| 102 | regulation of neurotransmitter secretion (GO:0046928) | 2.75262300 |
| 103 | macroautophagy (GO:0016236) | 2.74167495 |
| 104 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.73948189 |
| 105 | regulation of vesicle fusion (GO:0031338) | 2.72562960 |
| 106 | L-amino acid import (GO:0043092) | 2.72220890 |
| 107 | neurotransmitter transport (GO:0006836) | 2.71277127 |
| 108 | positive regulation of membrane potential (GO:0045838) | 2.70334051 |
| 109 | synapse assembly (GO:0007416) | 2.69280395 |
| 110 | oligosaccharide catabolic process (GO:0009313) | 2.68951328 |
| 111 | regulation of extracellular matrix disassembly (GO:0010715) | 2.66111905 |
| 112 | response to auditory stimulus (GO:0010996) | 2.65742841 |
| 113 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.65712413 |
| 114 | positive regulation of synapse assembly (GO:0051965) | 2.65642891 |
| 115 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.65324538 |
| 116 | positive regulation of mast cell degranulation (GO:0043306) | 2.65324538 |
| 117 | cellular potassium ion homeostasis (GO:0030007) | 2.63217213 |
| 118 | polyol catabolic process (GO:0046174) | 2.62701026 |
| 119 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.62339455 |
| 120 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.61095909 |
| 121 | innervation (GO:0060384) | 2.60271914 |
| 122 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.60012635 |
| 123 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.59806980 |
| 124 | protein targeting to Golgi (GO:0000042) | 2.58805407 |
| 125 | axoneme assembly (GO:0035082) | 2.58616601 |
| 126 | membrane assembly (GO:0071709) | 2.58434988 |
| 127 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.57039609 |
| 128 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.56593957 |
| 129 | mechanosensory behavior (GO:0007638) | 2.56119169 |
| 130 | phagosome maturation (GO:0090382) | 2.54967431 |
| 131 | regulation of neurotransmitter transport (GO:0051588) | 2.54950734 |
| 132 | regulation of glutamate secretion (GO:0014048) | 2.53804862 |
| 133 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.53437699 |
| 134 | regulation of synaptic plasticity (GO:0048167) | 2.52334093 |
| 135 | regulation of dendritic spine development (GO:0060998) | 2.51836086 |
| 136 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.51509354 |
| 137 | response to host (GO:0075136) | 2.51509354 |
| 138 | response to host defenses (GO:0052200) | 2.51509354 |
| 139 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.50895155 |
| 140 | behavioral response to cocaine (GO:0048148) | 2.50684292 |
| 141 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.50183426 |
| 142 | neuron remodeling (GO:0016322) | 2.49193937 |
| 143 | regulation of gamma-delta T cell activation (GO:0046643) | 2.48968599 |
| 144 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.48204514 |
| 145 | establishment of protein localization to Golgi (GO:0072600) | 2.48071023 |
| 146 | B cell receptor signaling pathway (GO:0050853) | 2.48061635 |
| 147 | regulation of mast cell degranulation (GO:0043304) | 2.47541214 |
| 148 | membrane hyperpolarization (GO:0060081) | 2.46629573 |
| 149 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.46116823 |
| 150 | amino acid import (GO:0043090) | 2.45660113 |
| 151 | adult walking behavior (GO:0007628) | 2.45382606 |
| 152 | amyloid precursor protein catabolic process (GO:0042987) | 2.45241692 |
| 153 | response to histamine (GO:0034776) | 2.45125925 |
| 154 | synapse organization (GO:0050808) | 2.45010840 |
| 155 | negative regulation of dendrite development (GO:2000171) | 2.44850660 |
| 156 | respiratory burst (GO:0045730) | 2.44126602 |
| 157 | positive regulation of macroautophagy (GO:0016239) | 2.43436574 |
| 158 | detection of external biotic stimulus (GO:0098581) | 2.43243442 |
| 159 | regulation of platelet aggregation (GO:0090330) | 2.42731374 |
| 160 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.42639951 |
| 161 | histamine secretion (GO:0001821) | 2.42402846 |
| 162 | regulation of neurotransmitter levels (GO:0001505) | 2.42142738 |
| 163 | lytic vacuole organization (GO:0080171) | 2.41896449 |
| 164 | lysosome organization (GO:0007040) | 2.41896449 |
| 165 | negative regulation of axon extension (GO:0030517) | 2.40984447 |
| 166 | learning (GO:0007612) | 2.40676314 |
| 167 | detection of other organism (GO:0098543) | 2.39640602 |
| 168 | energy homeostasis (GO:0097009) | 2.39579997 |
| 169 | central nervous system neuron axonogenesis (GO:0021955) | 2.39308016 |
| 170 | nitric oxide mediated signal transduction (GO:0007263) | 2.38843749 |
| 171 | regulation of protein glycosylation (GO:0060049) | 2.38723642 |
| 172 | negative regulation of synaptic transmission (GO:0050805) | 2.38248234 |
| 173 | membrane depolarization (GO:0051899) | 2.38066284 |
| 174 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.37911103 |
| 175 | negative regulation of interleukin-6 production (GO:0032715) | 2.37759157 |
| 176 | synaptic vesicle transport (GO:0048489) | 2.37723411 |
| 177 | establishment of synaptic vesicle localization (GO:0097480) | 2.37723411 |
| 178 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.37239427 |
| 179 | regulation of mast cell activation (GO:0033003) | 2.36704983 |
| 180 | import into cell (GO:0098657) | 2.36039303 |
| 181 | negative regulation of interleukin-17 production (GO:0032700) | 2.35669455 |
| 182 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.35609200 |
| 183 | neutrophil mediated immunity (GO:0002446) | 2.35100988 |
| 184 | regulation of memory T cell differentiation (GO:0043380) | 2.32278766 |
| 185 | positive regulation of B cell differentiation (GO:0045579) | 2.31789640 |
| 186 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.28193068 |
| 187 | regulation of cilium movement (GO:0003352) | 2.27992960 |
| 188 | positive regulation of leukocyte degranulation (GO:0043302) | 2.27975390 |
| 189 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.27728079 |
| 190 | potassium ion export (GO:0071435) | 2.26881763 |
| 191 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.23364178 |
| 192 | immunoglobulin mediated immune response (GO:0016064) | 2.23035868 |
| 193 | positive regulation of macrophage cytokine production (GO:0060907) | 2.22800063 |
| 194 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.22419355 |
| 195 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.22419355 |
| 196 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.22043184 |
| 197 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.21955405 |
| 198 | cellular ketone body metabolic process (GO:0046950) | 2.21201830 |
| 199 | early endosome to late endosome transport (GO:0045022) | 2.21199140 |
| 200 | negative regulation of bone resorption (GO:0045779) | 2.20985581 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.57024211 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.73896836 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.68587750 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.27362741 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.20937231 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.95318251 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.85636979 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.80025795 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.73990080 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.49615119 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.46463396 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.44457458 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.43551417 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.43551417 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.42671272 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.37187949 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.35293503 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.34966682 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.34038413 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.23542808 |
| 21 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.21627127 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.18151518 |
| 23 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.16513550 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.03640947 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.01069739 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.00569083 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.99678047 |
| 28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.96191443 |
| 29 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.95808851 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.88590272 |
| 31 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.88030909 |
| 32 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87557109 |
| 33 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.84650082 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.83170879 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.79791188 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.75238620 |
| 37 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.73568278 |
| 38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.73282648 |
| 39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.73251043 |
| 40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.72105499 |
| 41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.69527815 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.69292034 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.68476724 |
| 44 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.66051612 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.65956900 |
| 46 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.65116371 |
| 47 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65074104 |
| 48 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.63407542 |
| 49 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.63248430 |
| 50 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62781459 |
| 51 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.61006300 |
| 52 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.60050764 |
| 53 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.60039189 |
| 54 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.60031744 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.59289812 |
| 56 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.55593516 |
| 57 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.50985520 |
| 58 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49052383 |
| 59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48377460 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.48338220 |
| 61 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.47289194 |
| 62 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.46616252 |
| 63 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.44906380 |
| 64 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.43601614 |
| 65 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.41350785 |
| 66 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.41067159 |
| 67 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38001884 |
| 68 | VDR_22108803_ChIP-Seq_LS180_Human | 1.36763006 |
| 69 | SPI1_23127762_ChIP-Seq_K562_Human | 1.36555729 |
| 70 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35744891 |
| 71 | FUS_26573619_Chip-Seq_HEK293_Human | 1.35634264 |
| 72 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.35235387 |
| 73 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.34029301 |
| 74 | AR_25329375_ChIP-Seq_VCAP_Human | 1.32609863 |
| 75 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.30883293 |
| 76 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.29992897 |
| 77 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.27905226 |
| 78 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.27070693 |
| 79 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.23882141 |
| 80 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.23016483 |
| 81 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.22766739 |
| 82 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22539394 |
| 83 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.22443705 |
| 84 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.21681749 |
| 85 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.19621565 |
| 86 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.19487140 |
| 87 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19237953 |
| 88 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.18148368 |
| 89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17079891 |
| 90 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.16157865 |
| 91 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15682693 |
| 92 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.15561613 |
| 93 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.15233292 |
| 94 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.13893914 |
| 95 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.13891917 |
| 96 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13198562 |
| 97 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.13040158 |
| 98 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.12614393 |
| 99 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.11702390 |
| 100 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10334625 |
| 101 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10038757 |
| 102 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.09538270 |
| 103 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.08187580 |
| 104 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.08123170 |
| 105 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07796056 |
| 106 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07796056 |
| 107 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07758598 |
| 108 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.07391327 |
| 109 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.07148404 |
| 110 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06194070 |
| 111 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05967780 |
| 112 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05951783 |
| 113 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04748562 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.04588027 |
| 115 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04536607 |
| 116 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04505238 |
| 117 | TCF4_23295773_ChIP-Seq_U87_Human | 1.04077462 |
| 118 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.03890525 |
| 119 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.03880753 |
| 120 | TP53_16413492_ChIP-PET_HCT116_Human | 1.02530604 |
| 121 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02210823 |
| 122 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01578215 |
| 123 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01348251 |
| 124 | MYB_26560356_Chip-Seq_TH2_Human | 1.00760336 |
| 125 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.00356441 |
| 126 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.00129856 |
| 127 | AR_19668381_ChIP-Seq_PC3_Human | 0.99574499 |
| 128 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99514126 |
| 129 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99514126 |
| 130 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.98627335 |
| 131 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.98506368 |
| 132 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98195822 |
| 133 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98077052 |
| 134 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.97904932 |
| 135 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.97773428 |
| 136 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97717301 |
| 137 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.97320932 |
| 138 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.97088092 |
| 139 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.96233195 |
| 140 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95951513 |
| 141 | JUN_21703547_ChIP-Seq_K562_Human | 0.95514959 |
| 142 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.94827708 |
| 143 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.94572002 |
| 144 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94505057 |
| 145 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94411519 |
| 146 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.94267333 |
| 147 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.93672343 |
| 148 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.92557982 |
| 149 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.91614099 |
| 150 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.91284591 |
| 151 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.89993450 |
| 152 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.89993450 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.78656868 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.70482092 |
| 3 | MP0003172_abnormal_lysosome_physiology | 3.70747623 |
| 4 | MP0004270_analgesia | 3.46588812 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.42037464 |
| 6 | MP0003724_increased_susceptibility_to | 3.41102746 |
| 7 | MP0002254_reproductive_system_inflammat | 3.05157968 |
| 8 | MP0002063_abnormal_learning/memory/cond | 2.84176662 |
| 9 | MP0009745_abnormal_behavioral_response | 2.83426446 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.70934110 |
| 11 | MP0006082_CNS_inflammation | 2.69191937 |
| 12 | MP0002064_seizures | 2.68816481 |
| 13 | MP0005379_endocrine/exocrine_gland_phen | 2.61867411 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.58351107 |
| 15 | MP0001968_abnormal_touch/_nociception | 2.57126665 |
| 16 | MP0003303_peritoneal_inflammation | 2.56060935 |
| 17 | MP0002734_abnormal_mechanical_nocicepti | 2.54051569 |
| 18 | MP0009046_muscle_twitch | 2.47970064 |
| 19 | MP0001486_abnormal_startle_reflex | 2.47569168 |
| 20 | MP0000778_abnormal_nervous_system | 2.43402171 |
| 21 | MP0002572_abnormal_emotion/affect_behav | 2.40184150 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.37633004 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 2.35206795 |
| 24 | MP0002272_abnormal_nervous_system | 2.34139900 |
| 25 | MP0006054_spinal_hemorrhage | 2.33348891 |
| 26 | MP0002736_abnormal_nociception_after | 2.22550003 |
| 27 | MP0000569_abnormal_digit_pigmentation | 2.21963164 |
| 28 | MP0001440_abnormal_grooming_behavior | 2.21619079 |
| 29 | MP0001984_abnormal_olfaction | 2.20662857 |
| 30 | MP0002735_abnormal_chemical_nociception | 2.14120260 |
| 31 | MP0000015_abnormal_ear_pigmentation | 2.11380009 |
| 32 | MP0005423_abnormal_somatic_nervous | 2.09666858 |
| 33 | MP0002419_abnormal_innate_immunity | 2.02826290 |
| 34 | MP0002184_abnormal_innervation | 1.96232800 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.92792595 |
| 36 | MP0001501_abnormal_sleep_pattern | 1.91136420 |
| 37 | MP0003329_amyloid_beta_deposits | 1.89597845 |
| 38 | MP0004858_abnormal_nervous_system | 1.87479747 |
| 39 | MP0002067_abnormal_sensory_capabilities | 1.86082427 |
| 40 | MP0000685_abnormal_immune_system | 1.84802989 |
| 41 | MP0001970_abnormal_pain_threshold | 1.84231597 |
| 42 | MP0005646_abnormal_pituitary_gland | 1.83919039 |
| 43 | MP0005174_abnormal_tail_pigmentation | 1.83824112 |
| 44 | MP0005310_abnormal_salivary_gland | 1.82713361 |
| 45 | MP0003436_decreased_susceptibility_to | 1.82649451 |
| 46 | MP0002733_abnormal_thermal_nociception | 1.75665215 |
| 47 | MP0005387_immune_system_phenotype | 1.75477713 |
| 48 | MP0001790_abnormal_immune_system | 1.75477713 |
| 49 | MP0005671_abnormal_response_to | 1.73510245 |
| 50 | MP0006276_abnormal_autonomic_nervous | 1.73483005 |
| 51 | MP0005000_abnormal_immune_tolerance | 1.70450110 |
| 52 | MP0005171_absent_coat_pigmentation | 1.70368170 |
| 53 | MP0008569_lethality_at_weaning | 1.67613735 |
| 54 | MP0002557_abnormal_social/conspecific_i | 1.60420007 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.60285061 |
| 56 | MP0002148_abnormal_hypersensitivity_rea | 1.59812457 |
| 57 | MP0004742_abnormal_vestibular_system | 1.59638126 |
| 58 | MP0002693_abnormal_pancreas_physiology | 1.59598033 |
| 59 | MP0000955_abnormal_spinal_cord | 1.58380605 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.54544580 |
| 61 | MP0008877_abnormal_DNA_methylation | 1.53167347 |
| 62 | MP0000920_abnormal_myelination | 1.52063946 |
| 63 | MP0002452_abnormal_antigen_presenting | 1.51138613 |
| 64 | MP0002102_abnormal_ear_morphology | 1.50372253 |
| 65 | MP0001188_hyperpigmentation | 1.49965944 |
| 66 | MP0002723_abnormal_immune_serum | 1.47182122 |
| 67 | MP0008004_abnormal_stomach_pH | 1.44784738 |
| 68 | MP0004811_abnormal_neuron_physiology | 1.43476023 |
| 69 | MP0001502_abnormal_circadian_rhythm | 1.41914853 |
| 70 | MP0005386_behavior/neurological_phenoty | 1.41890603 |
| 71 | MP0004924_abnormal_behavior | 1.41890603 |
| 72 | MP0002882_abnormal_neuron_morphology | 1.41123956 |
| 73 | MP0009785_altered_susceptibility_to | 1.41023199 |
| 74 | MP0003283_abnormal_digestive_organ | 1.40377852 |
| 75 | MP0001800_abnormal_humoral_immune | 1.39072381 |
| 76 | MP0005025_abnormal_response_to | 1.37894641 |
| 77 | MP0003011_delayed_dark_adaptation | 1.37661251 |
| 78 | MP0001819_abnormal_immune_cell | 1.37537552 |
| 79 | MP0004885_abnormal_endolymph | 1.37456918 |
| 80 | MP0002420_abnormal_adaptive_immunity | 1.36965367 |
| 81 | MP0004883_abnormal_blood_vessel | 1.33024328 |
| 82 | MP0003634_abnormal_glial_cell | 1.31883026 |
| 83 | MP0002405_respiratory_system_inflammati | 1.30971006 |
| 84 | MP0003633_abnormal_nervous_system | 1.28943436 |
| 85 | MP0005397_hematopoietic_system_phenotyp | 1.26719109 |
| 86 | MP0001545_abnormal_hematopoietic_system | 1.26719109 |
| 87 | MP0002066_abnormal_motor_capabilities/c | 1.25077860 |
| 88 | MP0001529_abnormal_vocalization | 1.22805620 |
| 89 | MP0001905_abnormal_dopamine_level | 1.22681768 |
| 90 | MP0002163_abnormal_gland_morphology | 1.22043473 |
| 91 | MP0003690_abnormal_glial_cell | 1.18825237 |
| 92 | MP0002090_abnormal_vision | 1.18780738 |
| 93 | MP0005377_hearing/vestibular/ear_phenot | 1.17959274 |
| 94 | MP0003878_abnormal_ear_physiology | 1.17959274 |
| 95 | MP0005551_abnormal_eye_electrophysiolog | 1.17438410 |
| 96 | MP0003631_nervous_system_phenotype | 1.16387044 |
| 97 | MP0001845_abnormal_inflammatory_respons | 1.15325829 |
| 98 | MP0001299_abnormal_eye_distance/ | 1.14819738 |
| 99 | MP0004142_abnormal_muscle_tone | 1.13405016 |
| 100 | MP0003195_calcinosis | 1.12166999 |
| 101 | MP0000631_abnormal_neuroendocrine_gland | 1.10467547 |
| 102 | MP0002998_abnormal_bone_remodeling | 1.09086699 |
| 103 | MP0001177_atelectasis | 1.08944708 |
| 104 | MP0001944_abnormal_pancreas_morphology | 1.07878412 |
| 105 | MP0004808_abnormal_hematopoietic_stem | 1.07820485 |
| 106 | MP0002152_abnormal_brain_morphology | 1.06944534 |
| 107 | MP0008469_abnormal_protein_level | 1.06591267 |
| 108 | MP0002876_abnormal_thyroid_physiology | 1.06582559 |
| 109 | MP0000371_diluted_coat_color | 1.05112738 |
| 110 | MP0005075_abnormal_melanosome_morpholog | 1.04956919 |
| 111 | MP0010386_abnormal_urinary_bladder | 1.04125248 |
| 112 | MP0001963_abnormal_hearing_physiology | 1.04034020 |
| 113 | MP0010234_abnormal_vibrissa_follicle | 1.01667534 |
| 114 | MP0000343_altered_response_to | 1.01009890 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 1.00449660 |
| 116 | MP0003122_maternal_imprinting | 0.99266211 |
| 117 | MP0004510_myositis | 0.98172554 |
| 118 | MP0003045_fibrosis | 0.97711600 |
| 119 | MP0002295_abnormal_pulmonary_circulatio | 0.97358582 |
| 120 | MP0002166_altered_tumor_susceptibility | 0.97319871 |
| 121 | MP0000689_abnormal_spleen_morphology | 0.96692799 |
| 122 | MP0002752_abnormal_somatic_nervous | 0.95585690 |
| 123 | MP0002822_catalepsy | 0.95498156 |
| 124 | MP0003632_abnormal_nervous_system | 0.95159390 |
| 125 | MP0002928_abnormal_bile_duct | 0.94732883 |
| 126 | MP0002229_neurodegeneration | 0.93954595 |
| 127 | MP0003828_pulmonary_edema | 0.93212359 |
| 128 | MP0002909_abnormal_adrenal_gland | 0.91475131 |
| 129 | MP0010678_abnormal_skin_adnexa | 0.90320942 |
| 130 | MP0003879_abnormal_hair_cell | 0.89870257 |
| 131 | MP0003191_abnormal_cellular_cholesterol | 0.88051133 |
| 132 | MP0000716_abnormal_immune_system | 0.86907154 |
| 133 | MP0001485_abnormal_pinna_reflex | 0.86387346 |
| 134 | MP0000751_myopathy | 0.83968691 |
| 135 | MP0000372_irregular_coat_pigmentation | 0.83218075 |
| 136 | MP0002653_abnormal_ependyma_morphology | 0.83186111 |
| 137 | MP0001756_abnormal_urination | 0.82556597 |
| 138 | MP0006072_abnormal_retinal_apoptosis | 0.81815643 |
| 139 | MP0000604_amyloidosis | 0.81562543 |
| 140 | MP0003136_yellow_coat_color | 0.81398643 |
| 141 | MP0002837_dystrophic_cardiac_calcinosis | 0.80866215 |
| 142 | MP0004043_abnormal_pH_regulation | 0.80702298 |
| 143 | MP0001853_heart_inflammation | 0.80367797 |
| 144 | MP0005535_abnormal_body_temperature | 0.79583885 |
| 145 | MP0009764_decreased_sensitivity_to | 0.79533738 |
| 146 | MP0000013_abnormal_adipose_tissue | 0.79362220 |
| 147 | MP0005409_darkened_coat_color | 0.78886190 |
| 148 | MP0004019_abnormal_vitamin_homeostasis | 0.77745295 |
| 149 | MP0004134_abnormal_chest_morphology | 0.77081297 |
| 150 | MP0002078_abnormal_glucose_homeostasis | 0.76522513 |
| 151 | MP0002069_abnormal_eating/drinking_beha | 0.76461465 |
| 152 | MP0004145_abnormal_muscle_electrophysio | 0.76337453 |
| 153 | MP0005084_abnormal_gallbladder_morpholo | 0.76291751 |
| 154 | MP0003075_altered_response_to | 0.75335287 |
| 155 | MP0000639_abnormal_adrenal_gland | 0.74548107 |
| 156 | MP0001958_emphysema | 0.73798477 |
| 157 | MP0005595_abnormal_vascular_smooth | 0.73144934 |
| 158 | MP0000026_abnormal_inner_ear | 0.72635330 |
| 159 | MP0001943_abnormal_respiration | 0.70823250 |
| 160 | MP0003787_abnormal_imprinting | 0.70291919 |
| 161 | MP0003795_abnormal_bone_structure | 0.69783169 |
| 162 | MP0002009_preneoplasia | 0.68344505 |
| 163 | MP0005499_abnormal_olfactory_system | 0.68206130 |
| 164 | MP0005394_taste/olfaction_phenotype | 0.68206130 |
| 165 | MP0004085_abnormal_heartbeat | 0.66458943 |
| 166 | MP0003183_abnormal_peptide_metabolism | 0.66315235 |
| 167 | MP0005167_abnormal_blood-brain_barrier | 0.65223280 |
| 168 | MP0002751_abnormal_autonomic_nervous | 0.64496855 |
| 169 | MP0005187_abnormal_penis_morphology | 0.63697246 |
| 170 | MP0005253_abnormal_eye_physiology | 0.63549849 |
| 171 | MP0008874_decreased_physiological_sensi | 0.62913892 |
| 172 | MP0005195_abnormal_posterior_eye | 0.62096669 |
| 173 | MP0005623_abnormal_meninges_morphology | 0.61504114 |
| 174 | MP0001664_abnormal_digestion | 0.59857531 |
| 175 | MP0004484_altered_response_of | 0.59788373 |
| 176 | MP0005248_abnormal_Harderian_gland | 0.58768116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.46481205 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 4.73473090 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.55294150 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.55294150 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 4.55294150 |
| 6 | Myokymia (HP:0002411) | 4.41685173 |
| 7 | Epileptic encephalopathy (HP:0200134) | 4.37655416 |
| 8 | Atonic seizures (HP:0010819) | 4.32812577 |
| 9 | Focal seizures (HP:0007359) | 4.25589127 |
| 10 | Visual hallucinations (HP:0002367) | 4.02009036 |
| 11 | Febrile seizures (HP:0002373) | 3.92791854 |
| 12 | Hematochezia (HP:0002573) | 3.89572286 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 3.85360245 |
| 14 | Dysostosis multiplex (HP:0000943) | 3.80390116 |
| 15 | Neurofibrillary tangles (HP:0002185) | 3.73277398 |
| 16 | Abnormality of macrophages (HP:0004311) | 3.68100615 |
| 17 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.61440023 |
| 18 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.61440023 |
| 19 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.61440023 |
| 20 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.59890700 |
| 21 | Mucopolysacchariduria (HP:0008155) | 3.59890700 |
| 22 | Absence seizures (HP:0002121) | 3.41133969 |
| 23 | Stomatitis (HP:0010280) | 3.39469387 |
| 24 | Recurrent bacterial skin infections (HP:0005406) | 3.38491123 |
| 25 | Hypoglycemic seizures (HP:0002173) | 3.36413402 |
| 26 | Hyperventilation (HP:0002883) | 3.35308688 |
| 27 | Action tremor (HP:0002345) | 3.35164920 |
| 28 | Recurrent abscess formation (HP:0002722) | 3.32976413 |
| 29 | Dialeptic seizures (HP:0011146) | 3.29287718 |
| 30 | Cerebral inclusion bodies (HP:0100314) | 3.25919999 |
| 31 | Increased CSF protein (HP:0002922) | 3.24750763 |
| 32 | Generalized tonic-clonic seizures (HP:0002069) | 3.19240884 |
| 33 | Supranuclear gaze palsy (HP:0000605) | 3.17912541 |
| 34 | Eczematoid dermatitis (HP:0000976) | 3.11044352 |
| 35 | Insidious onset (HP:0003587) | 3.05550868 |
| 36 | Termporal pattern (HP:0011008) | 3.05550868 |
| 37 | Limb dystonia (HP:0002451) | 3.02425060 |
| 38 | Mutism (HP:0002300) | 3.01544798 |
| 39 | Pheochromocytoma (HP:0002666) | 2.97981426 |
| 40 | Abnormality of the corticospinal tract (HP:0002492) | 2.91002989 |
| 41 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.85834417 |
| 42 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.85834417 |
| 43 | Broad-based gait (HP:0002136) | 2.80620665 |
| 44 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.77889914 |
| 45 | Dysdiadochokinesis (HP:0002075) | 2.72144500 |
| 46 | Loss of speech (HP:0002371) | 2.72119154 |
| 47 | Chronic otitis media (HP:0000389) | 2.71262575 |
| 48 | Neuroendocrine neoplasm (HP:0100634) | 2.68558810 |
| 49 | Cutaneous melanoma (HP:0012056) | 2.68470636 |
| 50 | Ketoacidosis (HP:0001993) | 2.64957347 |
| 51 | Gait imbalance (HP:0002141) | 2.63398433 |
| 52 | Ankle clonus (HP:0011448) | 2.60902973 |
| 53 | Polyphagia (HP:0002591) | 2.58907225 |
| 54 | Progressive neurologic deterioration (HP:0002344) | 2.58729098 |
| 55 | Dysmetria (HP:0001310) | 2.58549621 |
| 56 | Aplasia involving bones of the extremities (HP:0009825) | 2.56757249 |
| 57 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.56757249 |
| 58 | Aplasia of the phalanges of the hand (HP:0009802) | 2.56757249 |
| 59 | Episodic fever (HP:0001954) | 2.55653416 |
| 60 | Absent speech (HP:0001344) | 2.55202275 |
| 61 | Megalencephaly (HP:0001355) | 2.52514206 |
| 62 | Abnormal eating behavior (HP:0100738) | 2.52030309 |
| 63 | Hemiparesis (HP:0001269) | 2.51245268 |
| 64 | Diplopia (HP:0000651) | 2.43480778 |
| 65 | Abnormality of binocular vision (HP:0011514) | 2.43480778 |
| 66 | True hermaphroditism (HP:0010459) | 2.41986906 |
| 67 | Amblyopia (HP:0000646) | 2.41843219 |
| 68 | Pancreatic fibrosis (HP:0100732) | 2.41474877 |
| 69 | Recurrent skin infections (HP:0001581) | 2.39720655 |
| 70 | Myositis (HP:0100614) | 2.39703407 |
| 71 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.35283374 |
| 72 | Drooling (HP:0002307) | 2.34760252 |
| 73 | Excessive salivation (HP:0003781) | 2.34760252 |
| 74 | Albinism (HP:0001022) | 2.32326104 |
| 75 | Prolonged bleeding time (HP:0003010) | 2.27372622 |
| 76 | Depression (HP:0000716) | 2.26510514 |
| 77 | Nephrogenic diabetes insipidus (HP:0009806) | 2.26076525 |
| 78 | Truncal ataxia (HP:0002078) | 2.26045427 |
| 79 | Cardiomegaly (HP:0001640) | 2.25946045 |
| 80 | Intention tremor (HP:0002080) | 2.22586240 |
| 81 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.22068835 |
| 82 | Gingival bleeding (HP:0000225) | 2.21908913 |
| 83 | Symptomatic seizures (HP:0011145) | 2.21826597 |
| 84 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.20452873 |
| 85 | Petechiae (HP:0000967) | 2.18933852 |
| 86 | Testicular neoplasm (HP:0010788) | 2.18731822 |
| 87 | Inappropriate behavior (HP:0000719) | 2.16799705 |
| 88 | Hypothermia (HP:0002045) | 2.15645567 |
| 89 | Lower limb muscle weakness (HP:0007340) | 2.14824433 |
| 90 | Anxiety (HP:0000739) | 2.14688891 |
| 91 | Progressive inability to walk (HP:0002505) | 2.14061815 |
| 92 | Abnormal hair whorl (HP:0010721) | 2.12517158 |
| 93 | Genetic anticipation (HP:0003743) | 2.12131321 |
| 94 | Spontaneous hematomas (HP:0007420) | 2.11241234 |
| 95 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.10739604 |
| 96 | Congenital primary aphakia (HP:0007707) | 2.10441436 |
| 97 | Basal ganglia calcification (HP:0002135) | 2.09962413 |
| 98 | Medial flaring of the eyebrow (HP:0010747) | 2.08138332 |
| 99 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.07488232 |
| 100 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.07488232 |
| 101 | Akinesia (HP:0002304) | 2.07162713 |
| 102 | Hyperglycemia (HP:0003074) | 2.06796948 |
| 103 | Urinary urgency (HP:0000012) | 2.06172471 |
| 104 | Epileptiform EEG discharges (HP:0011182) | 2.05581937 |
| 105 | Vaginal atresia (HP:0000148) | 2.05453803 |
| 106 | Genital tract atresia (HP:0001827) | 2.05257250 |
| 107 | Specific learning disability (HP:0001328) | 2.05233238 |
| 108 | Orchitis (HP:0100796) | 2.04978556 |
| 109 | Agitation (HP:0000713) | 2.04436737 |
| 110 | Amyloidosis (HP:0011034) | 2.04042796 |
| 111 | Gaze-evoked nystagmus (HP:0000640) | 2.03681451 |
| 112 | Spastic gait (HP:0002064) | 2.02447717 |
| 113 | Recurrent cutaneous fungal infections (HP:0011370) | 2.02210797 |
| 114 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.02210797 |
| 115 | Narrow nasal bridge (HP:0000446) | 2.02119548 |
| 116 | Parakeratosis (HP:0001036) | 2.01809808 |
| 117 | Stereotypic behavior (HP:0000733) | 2.00796355 |
| 118 | Nuclear cataract (HP:0100018) | 2.00478759 |
| 119 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.99710804 |
| 120 | Optic neuritis (HP:0100653) | 1.99022833 |
| 121 | Retrobulbar optic neuritis (HP:0100654) | 1.99022833 |
| 122 | Hypoglycemic coma (HP:0001325) | 1.97359678 |
| 123 | Synostosis involving the elbow (HP:0003938) | 1.97063144 |
| 124 | Humeroradial synostosis (HP:0003041) | 1.97063144 |
| 125 | Pancreatic cysts (HP:0001737) | 1.96566187 |
| 126 | EEG with generalized epileptiform discharges (HP:0011198) | 1.96078642 |
| 127 | Neuronal loss in central nervous system (HP:0002529) | 1.95056028 |
| 128 | Mediastinal lymphadenopathy (HP:0100721) | 1.94484364 |
| 129 | Blue irides (HP:0000635) | 1.94439984 |
| 130 | Recurrent fungal infections (HP:0002841) | 1.93878929 |
| 131 | Disinhibition (HP:0000734) | 1.93777900 |
| 132 | Scanning speech (HP:0002168) | 1.92389911 |
| 133 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.89495932 |
| 134 | Fetal akinesia sequence (HP:0001989) | 1.88163940 |
| 135 | Chronic obstructive pulmonary disease (HP:0006510) | 1.87917392 |
| 136 | Obstructive lung disease (HP:0006536) | 1.87917392 |
| 137 | Poor eye contact (HP:0000817) | 1.87542724 |
| 138 | Recurrent sinusitis (HP:0011108) | 1.86676633 |
| 139 | Abnormal ciliary motility (HP:0012262) | 1.86224689 |
| 140 | Torticollis (HP:0000473) | 1.86204880 |
| 141 | Thickened helices (HP:0000391) | 1.85900416 |
| 142 | Widely spaced teeth (HP:0000687) | 1.84173326 |
| 143 | Abnormality of salivation (HP:0100755) | 1.83442697 |
| 144 | Clumsiness (HP:0002312) | 1.83333449 |
| 145 | Hypsarrhythmia (HP:0002521) | 1.82181198 |
| 146 | Nasal polyposis (HP:0100582) | 1.80696770 |
| 147 | Protruding tongue (HP:0010808) | 1.80250263 |
| 148 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.77760822 |
| 149 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.77760822 |
| 150 | Postural tremor (HP:0002174) | 1.77721926 |
| 151 | Choroideremia (HP:0001139) | 1.77171273 |
| 152 | Nephronophthisis (HP:0000090) | 1.76943440 |
| 153 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.75932895 |
| 154 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.75732460 |
| 155 | Absent/shortened dynein arms (HP:0200106) | 1.75732460 |
| 156 | Amyotrophic lateral sclerosis (HP:0007354) | 1.75704951 |
| 157 | Apathy (HP:0000741) | 1.75608317 |
| 158 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.75470023 |
| 159 | Mitral stenosis (HP:0001718) | 1.74832203 |
| 160 | Large for gestational age (HP:0001520) | 1.74427310 |
| 161 | Gastrointestinal infarctions (HP:0005244) | 1.73877940 |
| 162 | Sensory axonal neuropathy (HP:0003390) | 1.73114112 |
| 163 | Postural instability (HP:0002172) | 1.71660425 |
| 164 | Cutaneous finger syndactyly (HP:0010554) | 1.71285174 |
| 165 | Generalized myoclonic seizures (HP:0002123) | 1.71102253 |
| 166 | Global brain atrophy (HP:0002283) | 1.70391791 |
| 167 | Molar tooth sign on MRI (HP:0002419) | 1.70040109 |
| 168 | Abnormality of midbrain morphology (HP:0002418) | 1.70040109 |
| 169 | Hypochromic microcytic anemia (HP:0004840) | 1.69764321 |
| 170 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.69569326 |
| 171 | Increased cerebral lipofuscin (HP:0011813) | 1.68715306 |
| 172 | Abnormality of the nasal mucosa (HP:0000433) | 1.67050207 |
| 173 | Asplenia (HP:0001746) | 1.62923471 |
| 174 | Chronic sinusitis (HP:0011109) | 1.61863812 |
| 175 | Arterial thrombosis (HP:0004420) | 1.61395229 |
| 176 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.61370393 |
| 177 | Asymmetric septal hypertrophy (HP:0001670) | 1.60812864 |
| 178 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.60479143 |
| 179 | Vasculitis (HP:0002633) | 1.59935131 |
| 180 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.59660256 |
| 181 | Ketosis (HP:0001946) | 1.57584760 |
| 182 | Sex reversal (HP:0012245) | 1.57133978 |
| 183 | Abnormal sex determination (HP:0012244) | 1.57133978 |
| 184 | Sensorimotor neuropathy (HP:0007141) | 1.56734232 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.52570824 |
| 2 | FRK | 4.38519323 |
| 3 | EPHA4 | 3.89847552 |
| 4 | MARK1 | 3.72634460 |
| 5 | ACVR1B | 3.07505902 |
| 6 | NTRK3 | 2.75836110 |
| 7 | MAP2K7 | 2.36382170 |
| 8 | MAP3K4 | 2.35486272 |
| 9 | TNK2 | 2.34240853 |
| 10 | MINK1 | 2.30266835 |
| 11 | IRAK1 | 2.06560510 |
| 12 | RIPK4 | 2.04468805 |
| 13 | MAP4K2 | 2.03365783 |
| 14 | TNIK | 1.97189582 |
| 15 | MAPK13 | 1.94212468 |
| 16 | MAP3K9 | 1.92812393 |
| 17 | IRAK4 | 1.90978384 |
| 18 | PLK2 | 1.82382102 |
| 19 | BLK | 1.78641260 |
| 20 | NTRK2 | 1.74789816 |
| 21 | DAPK2 | 1.71528455 |
| 22 | OXSR1 | 1.69636099 |
| 23 | PHKG1 | 1.61187612 |
| 24 | PHKG2 | 1.61187612 |
| 25 | PINK1 | 1.59372396 |
| 26 | MST4 | 1.55434411 |
| 27 | TYK2 | 1.52601620 |
| 28 | MAP3K12 | 1.50782061 |
| 29 | MAP2K4 | 1.45732619 |
| 30 | PAK6 | 1.43418229 |
| 31 | MAP4K1 | 1.43143924 |
| 32 | MOS | 1.42595806 |
| 33 | NTRK1 | 1.42051258 |
| 34 | STK39 | 1.40864249 |
| 35 | SGK223 | 1.40781905 |
| 36 | SGK494 | 1.40781905 |
| 37 | TEC | 1.40041738 |
| 38 | ADRBK2 | 1.38160436 |
| 39 | ERBB3 | 1.35539105 |
| 40 | JAK1 | 1.30492712 |
| 41 | MAP3K14 | 1.30274894 |
| 42 | ARAF | 1.29156917 |
| 43 | STK24 | 1.29149161 |
| 44 | FGFR3 | 1.29089760 |
| 45 | GRK5 | 1.26932558 |
| 46 | CSK | 1.26776033 |
| 47 | FGR | 1.26109463 |
| 48 | JAK3 | 1.24588151 |
| 49 | TGFBR2 | 1.24397199 |
| 50 | CDK5 | 1.23111318 |
| 51 | TRPM7 | 1.20533710 |
| 52 | PKN1 | 1.20111462 |
| 53 | SYK | 1.19472550 |
| 54 | HCK | 1.18072089 |
| 55 | CAMK2A | 1.18050110 |
| 56 | PRPF4B | 1.17751559 |
| 57 | DYRK2 | 1.14905956 |
| 58 | FES | 1.14774879 |
| 59 | IKBKE | 1.11530320 |
| 60 | PRKCE | 1.08347187 |
| 61 | NLK | 1.08261355 |
| 62 | CAMK2B | 1.07317458 |
| 63 | IRAK2 | 1.05473858 |
| 64 | MAP3K2 | 1.02901610 |
| 65 | LYN | 1.02796490 |
| 66 | CSF1R | 1.01975340 |
| 67 | UHMK1 | 1.01625851 |
| 68 | BTK | 1.01210289 |
| 69 | MATK | 1.00493928 |
| 70 | SGK2 | 1.00219432 |
| 71 | MAPKAPK5 | 0.99801997 |
| 72 | TBK1 | 0.99088197 |
| 73 | TAOK3 | 0.98219756 |
| 74 | MAP2K3 | 0.96648978 |
| 75 | ZAP70 | 0.96404687 |
| 76 | GRK1 | 0.96291464 |
| 77 | STK3 | 0.96268815 |
| 78 | KSR2 | 0.96001512 |
| 79 | PRKCG | 0.95295693 |
| 80 | PRKCH | 0.94304948 |
| 81 | SIK2 | 0.94129035 |
| 82 | PRKD2 | 0.93974356 |
| 83 | CDK19 | 0.93656012 |
| 84 | BMPR2 | 0.93653950 |
| 85 | CAMKK2 | 0.93521769 |
| 86 | BCR | 0.92401966 |
| 87 | IKBKB | 0.90883750 |
| 88 | KSR1 | 0.88902646 |
| 89 | CAMK2D | 0.86101819 |
| 90 | PAK3 | 0.84864202 |
| 91 | CSNK1G2 | 0.83984044 |
| 92 | KIT | 0.82804026 |
| 93 | NEK9 | 0.82732282 |
| 94 | CDK14 | 0.81577833 |
| 95 | JAK2 | 0.81114565 |
| 96 | STK16 | 0.80882387 |
| 97 | PRKCQ | 0.80873314 |
| 98 | PNCK | 0.79804457 |
| 99 | ITK | 0.78544553 |
| 100 | RET | 0.78241793 |
| 101 | GRK6 | 0.78107982 |
| 102 | DYRK1A | 0.76581048 |
| 103 | FER | 0.75622175 |
| 104 | CAMKK1 | 0.75473760 |
| 105 | HIPK2 | 0.75219449 |
| 106 | LIMK1 | 0.74875069 |
| 107 | MARK3 | 0.74637128 |
| 108 | PTK2B | 0.73801256 |
| 109 | MAPK7 | 0.73495464 |
| 110 | LCK | 0.73388639 |
| 111 | CDK18 | 0.72811344 |
| 112 | DDR2 | 0.71869249 |
| 113 | CDK15 | 0.71687672 |
| 114 | TXK | 0.71650744 |
| 115 | MAP3K1 | 0.70900735 |
| 116 | BRD4 | 0.70293762 |
| 117 | ROCK2 | 0.70276792 |
| 118 | SGK1 | 0.68129858 |
| 119 | NUAK1 | 0.67865877 |
| 120 | MAP3K6 | 0.67569995 |
| 121 | PIK3CA | 0.66972466 |
| 122 | NEK6 | 0.66529172 |
| 123 | BMPR1B | 0.65925149 |
| 124 | MUSK | 0.65732518 |
| 125 | WNK3 | 0.65390192 |
| 126 | DAPK1 | 0.63907594 |
| 127 | FGFR2 | 0.63116980 |
| 128 | CAMK1G | 0.62310215 |
| 129 | TYRO3 | 0.61707916 |
| 130 | SGK3 | 0.61687990 |
| 131 | RAF1 | 0.61516940 |
| 132 | ADRBK1 | 0.61247223 |
| 133 | CAMK2G | 0.61109274 |
| 134 | RPS6KA4 | 0.60983826 |
| 135 | PIK3CG | 0.60901293 |
| 136 | EPHA3 | 0.60868486 |
| 137 | MAP3K13 | 0.59025568 |
| 138 | CSNK1G3 | 0.58806515 |
| 139 | PDPK1 | 0.57944734 |
| 140 | CDK11A | 0.57445207 |
| 141 | MARK2 | 0.57332391 |
| 142 | STK11 | 0.56464210 |
| 143 | DYRK3 | 0.55260017 |
| 144 | YES1 | 0.55037105 |
| 145 | PRKCZ | 0.54359198 |
| 146 | GRK7 | 0.53071221 |
| 147 | EPHB1 | 0.52578573 |
| 148 | RPS6KA2 | 0.51645642 |
| 149 | EGFR | 0.50652590 |
| 150 | FYN | 0.50390042 |
| 151 | AKT3 | 0.47293251 |
| 152 | ABL1 | 0.45268087 |
| 153 | TAOK1 | 0.45103322 |
| 154 | MAP2K1 | 0.43153231 |
| 155 | ROCK1 | 0.43032000 |
| 156 | TIE1 | 0.42897245 |
| 157 | PRKG1 | 0.42336771 |
| 158 | CSNK1A1L | 0.41712540 |
| 159 | INSRR | 0.41419470 |
| 160 | MAP2K6 | 0.41287601 |
| 161 | PDK1 | 0.41251816 |
| 162 | MAPK12 | 0.40520729 |
| 163 | ERN1 | 0.39847696 |
| 164 | WNK4 | 0.39551876 |
| 165 | WNK1 | 0.36242040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.15047296 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.71153679 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.67319569 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.57078744 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.42473687 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.40609823 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.39822850 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.29161775 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 2.23525765 |
| 10 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.23234794 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.19089330 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 2.16224418 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 1.91902734 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.91811275 |
| 15 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.90064045 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.88885204 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.86009585 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.80700762 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.80186055 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.72315766 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.70813363 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.70530280 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.67410817 |
| 24 | Salivary secretion_Homo sapiens_hsa04970 | 1.66669638 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.59019136 |
| 26 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.58792525 |
| 27 | Insulin secretion_Homo sapiens_hsa04911 | 1.56942841 |
| 28 | Axon guidance_Homo sapiens_hsa04360 | 1.55468476 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.50275787 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.47475033 |
| 31 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.47270984 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.40015740 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.33707300 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.33514478 |
| 35 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.28789677 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.27422302 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.27208983 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.26630665 |
| 39 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.25559390 |
| 40 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.24750414 |
| 41 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.22402043 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 1.20064327 |
| 43 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.19035680 |
| 44 | Allograft rejection_Homo sapiens_hsa05330 | 1.17745580 |
| 45 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.17278508 |
| 46 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.16947380 |
| 47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.15418801 |
| 48 | Gap junction_Homo sapiens_hsa04540 | 1.14914344 |
| 49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.12611788 |
| 50 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.12206300 |
| 51 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.10658539 |
| 52 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.09614373 |
| 53 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.07279604 |
| 54 | Malaria_Homo sapiens_hsa05144 | 1.05530966 |
| 55 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.00763559 |
| 56 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.00043059 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98349719 |
| 58 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98038825 |
| 59 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.96772882 |
| 60 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.96421530 |
| 61 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.95493826 |
| 62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.95368578 |
| 63 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.94964084 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.94132042 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.93277869 |
| 66 | Melanogenesis_Homo sapiens_hsa04916 | 0.92738502 |
| 67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91298144 |
| 68 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.89414354 |
| 69 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.86942746 |
| 70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86901439 |
| 71 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86734296 |
| 72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.86542478 |
| 73 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.85848168 |
| 74 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.84664828 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83736134 |
| 76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.82999993 |
| 77 | Measles_Homo sapiens_hsa05162 | 0.81870330 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.81281308 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79799359 |
| 80 | Phototransduction_Homo sapiens_hsa04744 | 0.79277057 |
| 81 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.78101958 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77974701 |
| 83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.77959133 |
| 84 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77220267 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77003715 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.76985946 |
| 87 | Glioma_Homo sapiens_hsa05214 | 0.76013763 |
| 88 | Asthma_Homo sapiens_hsa05310 | 0.74784826 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74444558 |
| 90 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.74223469 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72574921 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72405279 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71826142 |
| 94 | Pertussis_Homo sapiens_hsa05133 | 0.70759157 |
| 95 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70195381 |
| 96 | Protein export_Homo sapiens_hsa03060 | 0.69892868 |
| 97 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.69892574 |
| 98 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.68854139 |
| 99 | ABC transporters_Homo sapiens_hsa02010 | 0.68604964 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68231277 |
| 101 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.68202580 |
| 102 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.67941192 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67432123 |
| 104 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67118202 |
| 105 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.66961528 |
| 106 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.66774482 |
| 107 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.66740453 |
| 108 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66307163 |
| 109 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65302797 |
| 110 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.64527817 |
| 111 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64119139 |
| 112 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63330668 |
| 113 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.63075287 |
| 114 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60756187 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60271712 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58523612 |
| 117 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58016676 |
| 118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56695568 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56508263 |
| 120 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.56461401 |
| 121 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55916630 |
| 122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.55465166 |
| 123 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54801894 |
| 124 | Hepatitis C_Homo sapiens_hsa05160 | 0.54582388 |
| 125 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54042172 |
| 126 | Salmonella infection_Homo sapiens_hsa05132 | 0.53762449 |
| 127 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53246989 |
| 128 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.52195805 |
| 129 | Prion diseases_Homo sapiens_hsa05020 | 0.51408838 |
| 130 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51338697 |
| 131 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.51286333 |
| 132 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.49667091 |
| 133 | Influenza A_Homo sapiens_hsa05164 | 0.49182425 |
| 134 | Peroxisome_Homo sapiens_hsa04146 | 0.49128392 |
| 135 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.48707730 |
| 136 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47705509 |
| 137 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46838721 |
| 138 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46576176 |
| 139 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.46235736 |
| 140 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45936085 |
| 141 | Shigellosis_Homo sapiens_hsa05131 | 0.45783929 |
| 142 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45186433 |
| 143 | Alcoholism_Homo sapiens_hsa05034 | 0.43886032 |
| 144 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42715430 |
| 145 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.42338601 |
| 146 | Endocytosis_Homo sapiens_hsa04144 | 0.41693883 |
| 147 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41590343 |
| 148 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41054235 |
| 149 | Parkinsons disease_Homo sapiens_hsa05012 | 0.39570694 |
| 150 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.38779498 |
| 151 | Melanoma_Homo sapiens_hsa05218 | 0.38664272 |
| 152 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38503883 |
| 153 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37903617 |
| 154 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.34032302 |
| 155 | Platelet activation_Homo sapiens_hsa04611 | 0.33454353 |
| 156 | Mineral absorption_Homo sapiens_hsa04978 | 0.33181374 |
| 157 | Colorectal cancer_Homo sapiens_hsa05210 | 0.32053254 |

